Corrigendum to “The neuroscience of depressionImplications for assessment and intervention” [Behav. Res. Ther. 62 (2014) 60–73] (S0005796714001375)(10.1016/j.brat.2014.08.008);The neuroscience of depression: Implications for assessment and intervention

Behaviour Research and Therapy

Volumn 62, Issue , 2014, Pages 60-73

  Singh, Manpreet K ^a   Gotlib, Ian H ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Assessment; Depression; Intervention; Neuroimaging; Neuroscience; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ESCITALOPRAM; FLUOXETINE; KETAMINE; MIRTAZAPINE; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ARTICLE; BOLD SIGNAL; BRAIN DEPTH STIMULATION; BRAIN SIZE; ELECTROCONVULSIVE THERAPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; MAJOR DEPRESSION; NERVE CELL NETWORK; NEUROIMAGING; NEUROMODULATION; NEUROSCIENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PROGNOSIS; PSYCHOTHERAPY; REMISSION; TRANSCRANIAL MAGNETIC STIMULATION; VOXEL BASED MORPHOMETRY; WHITE MATTER; BRAIN; DEPRESSIVE DISORDER; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

BRAIN; DEPRESSIVE DISORDER; HUMANS; NERVE NET; NEUROIMAGING; NEUROSCIENCES; PSYCHIATRIC STATUS RATING SCALES;

EID: 84910074506     PISSN: 00057967     EISSN: 1873622X     Source Type: Journal    
DOI: 10.1016/j.brat.2017.03.001     Document Type: Erratum

References (177)

1. Abelaira H.M., Réus G.Z., Quevedo J. Animal models as tools to study the pathophysiology of depression. Revista Brasileira de Psiquiatria (São Paulo, Brazil: 1999) 2013, 35(Suppl.2):S112-S120.
2. Ajilore O., Zhan L., Gadelkarim J., Zhang A., Feusner J.D., Yang S., et al. Constructing the resting state structural connectome. Frontiers in Neuroinformatics 2013, 7:30.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-5 2013, American Psychiatric Association, Washington, D.C. 5th ed.
4. Amsterdam J.D., Newberg A.B., Newman C.F., Shults J., Wintering N., Soeller I. Change over time in brain serotonin transporter binding in major depression: effects of therapy measured with [(123) I]-ADAM SPECT. Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging 2013, 23:469-476.
5. Anand A., Li Y., Wang Y., Gardner K., Lowe M.J. Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study. The Journal of Neuropsychiatry and Clinical Neurosciences 2007, 19:274-282.
6. Anand A., Li Y., Wang Y., Lowe M.J., Dzemidzic M. Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression. Psychiatry Research 2009, 171:189-198.
7. Anderson R.J., Frye M.A., Abulseoud O.A., Lee K.H., McGillivray J.A., Berk M., et al. Deep brain stimulation for treatment-resistant depression: efficacy, safety and mechanisms of action. Neuroscience and Biobehavioral Reviews 2012, 36:1920-1933.
8. Arnone D., McIntosh A.M., Ebmeier K.P., Munafò M.R., Anderson I.M. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2012, 22:1-16.
9. Arnone D., McKie S., Elliott R., Juhasz G., Thomas E.J., Downey D., et al. State-dependent changes in hippocampal grey matter in depression. Molecular Psychiatry 2013, 18:1265-1272.
10. Arnone D., McKie S., Elliott R., Thomas E.J., Downey D., Juhasz G., et al. Increased amygdala responses to sad but not fearful faces in major depression: relation to mood state and pharmacological treatment. The American Journal of Psychiatry 2012, 169:841-850.
11. Barnes J., Ridgway G.R., Bartlett J., Henley S.M.D., Lehmann M., Hobbs N., et al. Head size, age and gender adjustment in MRI studies: a necessary nuisance?. NeuroImage 2010, 53:1244-1255.
12. Barnhofer T., Brennan K., Crane C., Duggan D., Williams J.M.G. Acomparison of vulnerability factors in patients with persistent and remitting lifetime symptom course of depression. Journal of Affective Disorders 2014, 152-154:155-161.
13. Bellani M., Dusi N., Yeh P.H., Soares J.C., Brambilla P. The effects of antidepressants on human brain as detected by imaging studies. Focus on major depression. Progress In Neuro-Psychopharmacology & Biological Psychiatry 2011, 35:1544-1552.
14. Berggren A., Gustafson L., Höglund P., Johanson A. Along-term follow-up of clinical response and regional cerebral blood flow changes in depressed patients treated with ECT. Journal of Affective Disorders 2014, 167:235-243.
15. Bewernick B.H., Schlaepfer T.E. Chronic depression as a model disease for cerebral aging. Dialogues in Clinical Neuroscience 2013, 15:77-85.
16. Bolwig T.G. Neuroimaging and electroconvulsive therapy: a review. The Journal of ECT 2014, 30:138-142.
17. Bora E., Fornito A., Pantelis C., Yücel M. Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies. Journal of Affective Disorders 2012, 138:9-18.
18. Bora E., Harrison B.J., Davey C.G., Yücel M., Pantelis C. Meta-analysis of volumetric abnormalities in cortico-striatal-pallidal-thalamic circuits in major depressive disorder. Psychological Medicine 2012, 42:671-681.
19. Bortolozzi A., Celada P., Artigas F. Novel therapeutic strategies in major depression: focus on RNAi and ketamine. Current Pharmaceutical Design 2013, 20:3848-3860.
20. Brody A.L., Saxena S., Silverman D.H., Alborzian S., Fairbanks L.A., Phelps M.E., et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Research 1999, 91:127-139.
21. Brunoni A.R., Teng C.T., Correa C., Imamura M., Brasil-Neto J.P., Boechat R., et al. Neuromodulation approaches for the treatment of major depression: challenges and recommendations from a working group meeting. Arquivos de Neuro-Psiquiatria 2010, 68:433-451.
22. Buchheim A., Viviani R., Kessler H., Kächele H., Cierpka M., Roth G., et al. Changes in prefrontal-limbic function in major depression after 15 months of long-term psychotherapy. PloS one 2012, 7:e33745.
23. Bulloch A., Williams J., Lavorato D., Patten S. Recurrence of major depressive episodes is strongly dependent on the number of previous episodes. Depression and Anxiety 2014, 31:72-76.
24. Caetano S.C., Kaur S., Brambilla P., Nicoletti M., Hatch J.P., Sassi R.B., et al. Smaller cingulate volumes in unipolar depressed patients. Biological Psychiatry 2006, 59:702-706.
25. Carlson P.J., Diazgranados N., Nugent A.C., Ibrahim L., Luckenbaugh D.A., Brutsche N., et al. Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study. Biological Psychiatry 2013, 73:1213-1221.
26. Casey B.j., Jones R.M., Hare T.A. The adolescent brain. Annals of the New York Academy of Sciences 2008, 1124:111-126.
27. Chechko N., Augustin M., Zvyagintsev M., Schneider F., Habel U., Kellermann T. Brain circuitries involved in emotional interference task in major depression disorder. Journal of Affective Disorders 2013, 149:136-145.
28. Chen M.C., Hamilton J.P., Gotlib I.H. Decreased hippocampal volume in healthy girls at risk of depression. Archives of General Psychiatry 2010, 67:270-276.
29. Chen A.C., Oathes D.J., Chang C., Bradley T., Zhou Z.-W., Williams L.M., et al. Causal interactions between fronto-parietal central executive and default-mode networks in humans. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:19944-19949.
30. Chen C.H., Ridler K., Suckling J., Williams S., Fu C.H.Y., Merlo-Pich E., et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biological Psychiatry 2007, 62:407-414.
31. Cheng Y.Q., Xu J., Chai P., Li H.-J., Luo C.-R., Yang T., et al. Brain volume alteration and the correlations with the clinical characteristics in drug-naïve first-episode MDD patients: a voxel-based morphometry study. Neuroscience Letters 2010, 480:30-34.
32. Choi K.S., Holtzheimer P.E., Franco A.R., Kelley M.E., Dunlop B.W., Hu X.P., et al. Reconciling variable findings of white matter integrity in major depressive disorder. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2013, 39:1332-1339.
33. Cisler J.M., James G.A., Tripathi S., Mletzko T., Heim C., Hu X.P., et al. Differential functional connectivity within an emotion regulation neural network among individuals resilient and susceptible to the depressogenic effects of early life stress. Psychological Medicine 2013, 43:507-518.
34. Clasen P.C., Beevers C.G., Mumford J.A., Schnyer D.M. Cognitive control network connectivity in adolescent women with and without a parental history of depression. Developmental Cognitive Neuroscience 2014, 7:13-22.
35. Cohen A.S., Najolia G.M., Kim Y., Dinzeo T.J. On the boundaries of blunt affect/alogia across severe mental illness: implications for Research Domain Criteria. Schizophrenia Research 2012, 140:41-45.
36. Cole J., Costafreda S.G., McGuffin P., Fu C.H.Y. Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. Journal of Affective Disorders 2011, 134:483-487.
37. Cook I.A., Schrader L.M., Degiorgio C.M., Miller P.R., Maremont E.R., Leuchter A.F. Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy & Behavior: E&B 2013, 28:221-226.
38. Croarkin P.E., Wall C.A., McClintock S.M., Kozel F.A., Husain M.M., Sampson S.M. The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. The Journal of ECT 2010, 26:323-329.
39. Curry J.F., Aubuchon-Endsley N., Brancu M., Runnals J.J., Fairbank J.A. Lifetime major depression and comorbid disorders among current-era women veterans. Journal of Affective Disorders 2014, 152-154:434-440. VA Mid-Atlantic Mirecc Women Veterans Research Workgroup, VA Mid-Atlantic Mirecc Registry WorkgroupVA Mid-Atlantic Mirecc Registry Workgroup.
40. Dearing K.F., Gotlib I.H. Interpretation of ambiguous information in girls at risk for depression. Journal of Abnormal Child Psychology 2009, 37:79-91.
41. Dekker M.C., Ferdinand R.F., van Lang N.D.J., Bongers I.L., van der Ende J., Verhulst F.C. Developmental trajectories of depressive symptoms from early childhood to late adolescence: gender differences and adult outcome. Journal of Child Psychology and Psychiatry, and Allied Disciplines 2007, 48:657-666.
42. Delaveau P., Jabourian M., Lemogne C., Guionnet S., Bergouignan L., Fossati P. Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies. Journal of Affective Disorders 2011, 130:66-74.
43. Diener C., Kuehner C., Brusniak W., Ubl B., Wessa M., Flor H. Ameta-analysis of neurofunctional imaging studies of emotion and cognition in major depression. NeuroImage 2012, 61:677-685.
44. Dillon D.G., Rosso I.M., Pechtel P., Killgore W.D.S., Rauch S.L., Pizzagalli D.A. Peril and pleasure: an rdoc-inspired examination of threat responses and reward processing in anxiety and depression. Depression and Anxiety 2014, 31:233-249.
45. Downar J., Geraci J., Salomons T.V., Dunlop K., Wheeler S., McAndrews M.P., et al. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression. Biological Psychiatry 2013, 76(3):176-185. 2014 Aug 1.
46. Doyle O.M., De Simoni S., Schwarz A.J., Brittain C., O'Daly O.G., Williams S.C.R., et al. Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents. The Journal of Pharmacology and Experimental Therapeutics 2013, 345:151-160.
47. Drevets W.C. Functional neuroimaging studies of depression: the anatomy of melancholia. Annual Review of Medicine 1998, 49:341-361.
48. Dunlop B.W., Binder E.B., Cubells J.F., Goodman M.M., Kelley M.E., Kinkead B., et al. Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials 2012, 13:106.
49. Fales C.L., Barch D.M., Rundle M.M., Mintun M.A., Mathews J., Snyder A.Z., et al. Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression. Journal of Affective Disorders 2009, 112:206-211.
50. Farah M.J., Gillihan S.J. The puzzle of neuroimaging and psychiatric diagnosis: technology and nosology in an evolving discipline. AJOB Neuroscience 2012, 3:31-41.
51. Fitzgerald P.B., Laird A.R., Maller J., Daskalakis Z.J. Ameta-analytic study of changes in brain activation in depression. Human Brain Mapping 2008, 29:683-695.
52. Flint J., Kendler K.S. The genetics of major depression. Neuron 2014, 81:484-503.
53. Foland-Ross L.C., Gotlib I.H. Cognitive and neural aspects of information processing in major depressive disorder: an integrative perspective. Frontiers in Psychology 2012, 3:489.
54. Foland-Ross L.C., Hamilton J.P., Joormann J., Berman M.G., Jonides J., Gotlib I.H. The neural basis of difficulties disengaging from negative irrelevant material in major depression. Psychological Science 2013, 24:334-344.
55. Fond G., Loundou A., Rabu C., Macgregor A., Lançon C., Brittner M., et al. Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology 2014, 10.1007/s00213-014-3664-5.
56. Fried E.I., Nesse R.M., Zivin K., Guille C., Sen S. Depression is more than the sum score of its parts: individual DSM symptoms have different risk factors. Psychological Medicine 2013, 1-10.
57. Fu C.H.Y., Costafreda S.G. Neuroimaging-based biomarkers in psychiatry: clinical opportunities of a paradigm shift. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 2013, 58:499-508.
58. Fu C.H.Y., Steiner H., Costafreda S.G. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiology of Disease 2013, 52:75-83.
59. Fu C.H.Y., Williams S.C.R., Brammer M.J., Suckling J., Kim J., Cleare A.J., et al. Neural responses to happy facial expressions in major depression following antidepressant treatment. The American Journal of Psychiatry 2007, 164:599-607.
60. Fu C.H.Y., Williams S.C.R., Cleare A.J., Scott J., Mitterschiffthaler M.T., Walsh N.D., et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biological Psychiatry 2008, 64:505-512.
61. Furey M.L., Drevets W.C., Hoffman E.M., Frankel E., Speer A.M., Zarate C.A. Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder. JAMA Psychiatry 2013, 70:280-290.
62. Goldapple K., Segal Z., Garson C., Lau M., Bieling P., Kennedy S., et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry 2004, 61:34-41.
63. Goodwin R.D., Gotlib I.H. Gender differences in depression: the role of personality factors. Psychiatry Research 2004, 126:135-142.
64. Gotlib I.H., Hamilton J.P., Cooney R.E., Singh M.K., Henry M.L., Joormann J. Neural processing of reward and loss in girls at risk for major depression. Archives of General Psychiatry 2010, 67:380-387.
65. Gotlib I.H., Joormann J. Cognition and depression: current status and future directions. Annual Review of Clinical Psychology 2010, 6:285-312.
66. Gotlib I.H., Joormann J., Foland-Ross L.C. Understanding familial risk for depression: a 25-year perspective. Perspectives on Psychological Science 2014, 9:94-108.
67. Gotlib I.H., Joormann J., Minor K.L., Hallmayer J. HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biological Psychiatry 2008, 63:847-851.
68. Graham J., Salimi-Khorshidi G., Hagan C., Walsh N., Goodyer I., Lennox B., et al. Meta-analytic evidence for neuroimaging models of depression: state or trait?. Journal of Affective Disorders 2013, 151:423-431.
69. Greicius M.D., Flores B.H., Menon V., Glover G.H., Solvason H.B., Kenna H., et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biological Psychiatry 2007, 62:429-437.
70. Groenewold N.A., Opmeer E.M., de Jonge P., Aleman A., Costafreda S.G. Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies. Neuroscience and Biobehavioral Reviews 2013, 37:152-163.
71. Guo W., Liu F., Xue Z., Gao K., Liu Z., Xiao C., et al. Abnormal resting-state cerebellar-cerebral functional connectivity in treatment-resistant depression and treatment sensitive depression. Progress In Neuro-Psychopharmacology & Biological Psychiatry 2013, 44:51-57.
72. Guo W., Liu F., Xue Z., Gao K., Wu R., Ma C., et al. Altered white matter integrity in young adults with first-episode, treatment-naive, and treatment-responsive depression. Neuroscience Letters 2012, 522:139-144.
73. Hajek T., Carrey N., Alda M. Neuroanatomical abnormalities as risk factors for bipolar disorder. Bipolar Disorders 2005, 7:393-403.
74. Hamilton J.P., Chen M.C., Gotlib I.H. Neural systems approaches to understanding major depressive disorder: an intrinsic functional organization perspective. Neurobiology of Disease 2013, 52:4-11.
75. Hamilton J.P., Etkin A., Furman D.J., Lemus M.G., Johnson R.F., Gotlib I.H. Functional neuroimaging of Major Depressive Disorder: a meta-analysis and new integration of baseline activation and neural response data. American Journal of Psychiatry 2012, 169:693-703.
76. Hamilton J.P., Siemer M., Gotlib I.H. Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Molecular Psychiatry 2008, 13:993-1000.
77. Hayley S., Litteljohn D. Neuroplasticity and the next wave of antidepressant strategies. Frontiers in Cellular Neuroscience 2013, 7:218.
78. Hirschfeld R.M.A. The epidemiology of depression and the evolution of treatment. The Journal of Clinical Psychiatry 2012, 73(Suppl.1):5-9.
79. Huang H., Fan X., Williamson D.E., Rao U. White matter changes in healthy adolescents at familial risk for unipolar depression: a diffusion tensor imaging study. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2011, 36:684-691.
80. Joormann J., Cooney R.E., Henry M.L., Gotlib I.H. Neural correlates of automatic mood regulation in girls at high risk for depression. Journal of Abnormal Psychology 2012, 121:61-72.
81. Joormann J., Gilbert K., Gotlib I.H. Emotion identification in girls at high risk for depression. Journal of Child Psychology and Psychiatry, and Allied Disciplines 2010, 51:575-582.
82. Joormann J., Talbot L., Gotlib I.H. Biased processing of emotional information in girls at risk for depression. Journal of Abnormal Psychology 2007, 116:135-143.
83. Kanske P., Heissler J., Schönfelder S., Wessa M. Neural correlates of emotion regulation deficits in remitted depression: the influence of regulation strategy, habitual regulation use, and emotional valence. NeuroImage 2012, 61:686-693.
84. Kellner C.H., Kaicher D.C., Banerjee H., Knapp R.G., Shapiro R.J., Briggs M.C., et al. Depression severity in Electroconvulsive Therapy (ECT) versus pharmacotherapy trials. The Journal of ECT 2014, 10.1097/YCT.0000000000000135.
85. Kempton M.J., Salvador Z., Munafò M.R., Geddes J.R., Simmons A., Frangou S., et al. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Archives of General Psychiatry 2011, 68:675-690.
86. Kennedy S.H., Giacobbe P. Treatment resistant depression - advances in somatic therapies. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 2007, 19:279-287.
87. Kennedy S.H., Javanmard M., Vaccarino F.J. Areview of functional neuroimaging in mood disorders: positron emission tomography and depression. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie 1997, 42:467-475.
88. Kennedy S.H., Konarski J.Z., Segal Z.V., Lau M.A., Bieling P.J., McIntyre R.S., et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. The American Journal of Psychiatry 2007, 164:778-788.
89. Kerestes R., Davey C.G., Stephanou K., Whittle S., Harrison B.J. Functional brain imaging studies of youth depression: a systematic review. NeuroImage: Clinical 2013, 4:209-231.
90. Kerestes R., Ladouceur C.D., Meda S., Nathan P.J., Blumberg H.P., Maloney K., et al. Abnormal prefrontal activity subserving attentional control of emotion in remitted depressed patients during a working memory task with emotional distracters. Psychological Medicine 2012, 42:29-40.
91. Klein D.N., Glenn C.R., Kosty D.B., Seeley J.R., Rohde P., Lewinsohn P.M. Predictors of first lifetime onset of major depressive disorder in young adulthood. Journal of Abnormal Psychology 2013, 122:1-6.
92. Kong L., Wu F., Tang Y., Ren L., Kong D., Liu Y., et al. Frontal-subcortical volumetric deficits in single episode, medication-naïve depressed patients and the effects of 8 weeks fluoxetine treatment: a VBM-DARTEL study. PloS One 2014, 9:e79055.
93. Koolschijn P.C.M.P., van Haren N.E.M., Lensvelt-Mulders G.J.L.M., Hulshoff Pol H.E., Kahn R.S. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Human Brain Mapping 2009, 30:3719-3735.
94. Korb A.S., Hunter A.M., Cook I.A., Leuchter A.F. Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Research 2011, 192:188-194.
95. Korgaonkar M.S., Grieve S.M., Etkin A., Koslow S.H., Williams L.M. Using standardized fMRI protocols to identify patterns of prefrontal circuit dysregulation that are common and specific to cognitive and emotional tasks in major depressive disorder: first wave results from the iSPOT-D study. Neuropsychopharmacology 2013, 38:863-871.
96. Kühn S., Vanderhasselt M.-A., De Raedt R., Gallinat J. Why ruminators won't stop: the structural and resting state correlates of rumination and its relation to depression. Journal of Affective Disorders 2012, 141:352-360.
97. Lai C.H. Patterns of cortico-limbic activations during visual processing of sad faces in depression patients: a coordinate-based meta-analysis. The Journal of Neuropsychiatry and Clinical Neurosciences 2014, 26:34-43.
98. Langenecker S.A., Kennedy S.E., Guidotti L.M., Briceno E.M., Own L.S., Hooven T., et al. Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder. Biological Psychiatry 2007, 62:1272-1280.
99. Lewinsohn P.M., Allen N.B., Seeley J.R., Gotlib I.H. First onset versus recurrence of depression: differential processes of psychosocial risk. Journal of Abnormal Psychology 1999, 108:483-489.
100. Li C.T., Lin C.P., Chou K.H., Chen I.Y., Hsieh J.C., Wu C.L., et al. Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study. NeuroImage 2010, 50:347-356.
101. Liao Y., Huang X., Wu Q., Yang C., Kuang W., Du M., et al. Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD. Journal of Psychiatry & Neuroscience 2013, 38:49-56.
102. Lisiecka D., Meisenzahl E., Scheuerecker J., Schoepf V., Whitty P., Chaney A., et al. Neural correlates of treatment outcome in major depression. The International Journal of Neuropsychopharmacology 2011, 14:521-534.
103. Liston C., Chen A.C., Zebley B.D., Drysdale A.T., Gordon R., Leuchter B., et al. Default mode network mechanisms of transcranial magnetic stimulation in depression. Biological Psychiatry 2014, 10.1016/j.biopsych.2014.01.023.
104. Liu F., Guo W., Yu D., Gao Q., Gao K., Xue Z., et al. Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans. PloS One 2012, 7:e40968.
105. Liu C.H., Jing B., Ma X., Xu P.F., Zhang Y., Li F., et al. Voxel-based morphometry study of the insular cortex in female patients with current and remitted depression. Neuroscience 2014, 262:190-199.
106. Lyden H., Espinoza R.T., Pirnia T., Clark K., Joshi S.H., Leaver A.M., et al. Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression. Translational Psychiatry 2014, 4:e380.
107. MacQueen G.M., Yucel K., Taylor V.H., Macdonald K., Joffe R. Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biological Psychiatry 2008, 64:880-883.
108. Malykhin N.V., Carter R., Seres P., Coupland N.J. Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment. Journal of Psychiatry & Neuroscience 2010, 35:337-343.
109. Marchetti I., Koster E.H.W., Sonuga-Barke E.J., De Raedt R. The default mode network and recurrent depression: a neurobiological model of cognitive risk factors. Neuropsychology Review 2012, 22:229-251.
110. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
111. McGirr A., Berlim M.T., Bond D.J., Fleck M.P., Yatham L.N., Lam R.W. Asystematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychological Medicine 2014, 1-12.
112. McGrath C.L., Kelley M.E., Holtzheimer P.E., Dunlop B.W., Craighead W.E., Franco A.R., et al. Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry 2013, 70:821-829.
113. McKinnon M.C., Yucel K., Nazarov A., MacQueen G.M. Ameta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. Journal of Psychiatry & Neuroscience 2009, 34:41-54.
114. Meng C., Brandl F., Tahmasian M., Shao J., Manoliu A., Scherr M., et al. Aberrant topology of striatum's connectivity is associated with the number of episodes in depression. Brain 2014, 137:598-609.
115. Miller J.M., Oquendo M.A., Ogden R.T., Mann J.J., Parsey R.V. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. Journal of Psychiatric Research 2008, 42:1137-1144.
116. Miller J.M., Schneck N., Siegle G.J., Chen Y., Ogden R.T., Kikuchi T., et al. fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study. Psychiatry Research 2013, 214:296-305.
117. Mills N.T., Scott J.G., Wray N.R., Cohen-Woods S., Baune B.T. Research review: the role of cytokines in depression in adolescents: a systematic review. Journal of Child Psychology and Psychiatry 2013, 54:816-835.
118. Milne A.M.B., MacQueen G.M., Hall G.B.C. Abnormal hippocampal activation in patients with extensive history of major depression: an fMRI study. Journal of Psychiatry & Neuroscience: JPN 2012, 37:28-36.
119. Monk C.S., Klein R.G., Telzer E.H., Schroth E.A., Mannuzza S., Moulton J.L., et al. Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression. The American Journal of Psychiatry 2008, 165:90-98.
120. Moresco R.M., Matarrese M., Fazio F. PET and SPET molecular imaging: focus on serotonin system. Current Topics in Medicinal Chemistry 2006, 6:2027-2034.
121. Moussavi S., Chatterji S., Verdes E., Tandon A., Patel V., Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007, 370:851-858.
122. Moylan S., Maes M., Wray N.R., Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Molecular Psychiatry 2013, 18:595-606.
123. Nejad A.B., Fossati P., Lemogne C. Self-referential processing, rumination, and cortical midline structures in major depression. Frontiers in Human Neuroscience 2013, 7:666.
124. Niciu M.J., Mathews D.C., Nugent A.C., Ionescu D.F., Furey M.L., Richards E.M., et al. Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants. Depression and Anxiety 2013, 31:297-307.
125. Norbury R., Godlewska B., Cowen P.J. When less is more: a functional magnetic resonance imaging study of verbal working memory in remitted depressed patients. Psychological Medicine 2013, 1-7.
126. Northoff G., Wiebking C., Feinberg T., Panksepp J. The "resting-state hypothesis" of major depressive disorder - a translational subcortical-cortical framework for a system disorder. Neuroscience and biobehavioral reviews 2011, 35:1929-1945.
127. Pascual-Leone A., Tormos J.M., Keenan J., Tarazona F., Cañete C., Catalá M.D. Study and modulation of human cortical excitability with transcranial magnetic stimulation. Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society 1998, 15:333-343.
128. Perlis R.H. Pharmacogenomic testing and personalized treatment of depression. Clinical Chemistry 2014, 60:53-59.
129. Peterson B.S., Warner V., Bansal R., Zhu H., Hao X., Liu J., et al. Cortical thinning in persons at increased familial risk for major depression. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:6273-6278.
130. Rive M.M., van Rooijen G., Veltman D.J., Phillips M.L., Schene A.H., Ruhé H.G. Neural correlates of dysfunctional emotion regulation in major depressive disorder. A systematic review of neuroimaging studies. Neuroscience and Biobehavioral Reviews 2013, 37:2529-2553.
131. Rizvi S.J., Salomons T.V., Konarski J.Z., Downar J., Giacobbe P., McIntyre R.S., et al. Neural response to emotional stimuli associated with successful antidepressant treatment and behavioral activation. Journal of Affective Disorders 2013, 151:573-581.
132. Rosenblau G., Sterzer P., Stoy M., Park S., Friedel E., Heinz A., et al. Functional neuroanatomy of emotion processing in major depressive disorder is altered after successful antidepressant therapy. Journal of Psychopharmacology 2012, 26:1424-1433.
133. Sacher J., Neumann J., Fünfstück T., Soliman A., Villringer A., Schroeter M.L. Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. Journal of Affective Disorders 2012, 140:142-148.
134. Salvadore G., Cornwell B.R., Sambataro F., Latov D., Colon-Rosario V., Carver F., et al. Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2010, 35:1415-1422.
135. Salvadore G., Nugent A.C., Lemaitre H., Luckenbaugh D.A., Tinsley R., Cannon D.M., et al. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. NeuroImage 2011, 54:2643-2651.
136. Sambataro F., Wolf N.D., Pennuto M., Vasic N., Wolf R.C. Revisiting default mode network function in major depression: evidence for disrupted subsystem connectivity. Psychological Medicine 2013, 1-11.
137. Samson A.C., Meisenzahl E., Scheuerecker J., Rose E., Schoepf V., Wiesmann M., et al. Brain activation predicts treatment improvement in patients with major depressive disorder. Journal of Psychiatric Research 2011, 45:1214-1222.
138. Sato S., Yeh T.L. Challenges in treating patients with major depressive disorder: the impact of biological and social factors. CNS Drugs 2013, 27(Suppl.1):S5-S10.
139. Schlaepfer T.E., Bewernick B.H. Neuromodulation for treatment resistant depression: state of the art and recommendations for clinical and scientific conduct. Brain Topography 2014, 27:12-19.
140. Shanahan L., Copeland W.E., Costello E.J., Angold A. Child-, adolescent- and young adult-onset depressions: differential risk factors in development?. Psychological Medicine 2011, 41:2265-2274.
141. Sharp C., Kim S., Herman L., Pane H., Reuter T., Strathearn L. Major depression in mothers predicts reduced ventral striatum activation in adolescent female offspring with and without depression. Journal of Abnormal Psychology 2014, 123:298-309.
142. Sheline Y.I., Gado M.H., Kraemer H.C. Untreated depression and hippocampal volume loss. The American Journal of Psychiatry 2003, 160:1516-1518.
143. Sheline Y.I., Price J.L., Yan Z., Mintun M.A. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:11020-11025.
144. Siegle G.J., Carter C.S., Thase M.E. Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. The American Journal of Psychiatry 2006, 163:735-738.
145. Singh M.K., Kesler S.R., Hadi Hosseini S.M., Kelley R.G., Amatya D., Hamilton J.P., et al. Anomalous gray matter structural networks in major depressive disorder. Biological Psychiatry 2013, 74:777-785.
146. Sneed J.R., Culang-Reinlieb M.E., Brickman A.M., Gunning-Dixon F.M., Johnert L., Garcon E., et al. MRI signal hyperintensities and failure to remit following antidepressant treatment. Journal of Affective Disorders 2011, 135(1-3):315-320.
147. Sperduti M., Martinelli P., Kalenzaga S., Devauchelle A.-D., Lion S., Malherbe C., et al. Don't be too strict with yourself! Rigid negative self-representation in healthy subjects mimics the neurocognitive profile of depression for autobiographical memory. Frontiers in Behavioral Neuroscience 2013, 7:41.
148. Steele J.D., Christmas D., Eljamel M.S., Matthews K. Anterior cingulotomy for major depression: clinical outcome and relationship to lesion characteristics. Biological Psychiatry 2008, 63:670-677.
149. Steele J.D., Currie J., Lawrie S.M., Reid I. Prefrontal cortical functional abnormality in major depressive disorder: a stereotactic meta-analysis. Journal of Affective Disorders 2007, 101:1-11.
150. Stoy M., Schlagenhauf F., Sterzer P., Bermpohl F., Hägele C., Suchotzki K., et al. Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram. Journal of Psychopharmacology 2012, 26:677-688.
151. Stuhrmann A., Suslow T., Dannlowski U. Facial emotion processing in major depression: a systematic review of neuroimaging findings. Biology of Mood & Anxiety Disorders 2011, 1:10.
152. Suzuki H., Botteron K.N., Luby J.L., Belden A.C., Gaffrey M.S., Babb C.M., et al. Structural-functional correlations between hippocampal volume and cortico-limbic emotional responses in depressed children. Cognitive, Affective & Behavioral Neuroscience 2013, 13:135-151.
153. Tahmasian M., Knight D.C., Manoliu A., Schwerthöffer D., Scherr M., Meng C., et al. Aberrant intrinsic connectivity of hippocampus and amygdala overlap in the fronto-insular and dorsomedial-prefrontal cortex in major depressive disorder. Frontiers in Human Neuroscience 2013, 7:639.
154. Takahashi T., Yücel M., Lorenzetti V., Tanino R., Whittle S., Suzuki M., et al. Volumetric MRI study of the insular cortex in individuals with current and past major depression. Journal of Affective Disorders 2010, 121:231-238.
155. Tao R., Calley C.S., Hart J., Mayes T.L., Nakonezny P.A., Lu H., et al. Brain activity in adolescent major depressive disorder before and after fluoxetine treatment. The American Journal of Psychiatry 2012, 169:381-388.
156. Tham M.W., Woon P.S., Sum M.Y., Lee T.-S., Sim K. White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies. Journal of Affective Disorders 2011, 132:26-36.
157. Thompson P.M., Giedd J.N., Woods R.P., MacDonald D., Evans A.C., Toga A.W. Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature 2000, 404:190-193.
158. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. Journal of the American Medical Association 2013, 310:591-608. US Burden of Disease Collaborators.
159. Van Eijndhoven P., van Wingen G., Katzenbauer M., Groen W., Tepest R., Fernández G., et al. Paralimbic cortical thickness in first-episode depression: evidence for trait-related differences in mood regulation. The American Journal of Psychiatry 2013, 170:1477-1486.
160. Van Tol M.-J., Li M., Metzger C.D., Hailla N., Horn D.I., Li W., et al. Local cortical thinning links to resting-state disconnectivity in major depressive disorder. Psychological Medicine 2013, 1-13.
161. Van Wingen G.A., van Eijndhoven P., Cremers H.R., Tendolkar I., Verkes R.J., Buitelaar J.K., et al. Neural state and trait bases of mood-incongruent memory formation and retrieval in first-episode major depression. Journal of Psychiatric Research 2010, 44:527-534.
162. Vasic N., Walter H., Höse A., Wolf R.C. Gray matter reduction associated with psychopathology and cognitive dysfunction in unipolar depression: a voxel-based morphometry study. Journal of Affective Disorders 2008, 109:107-116.
163. Victor T.A., Furey M.L., Fromm S.J., Ohman A., Drevets W.C. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Archives of General Psychiatry 2010, 67:1128-1138.
164. Victor T.A., Furey M.L., Fromm S.J., Öhman A., Drevets W.C. Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder. The International Journal of Neuropsychopharmacology 2013, 16:2195-2208.
165. Videbech P., Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. The American Journal of Psychiatry 2004, 161:1957-1966.
166. Villanueva R. Neurobiology of major depressive disorder. Neural Plasticity 2013, 2013:873278.
167. Vrieze E., Demyttenaere K., Bruffaerts R., Hermans D., Pizzagalli D.A., Sienaert P., et al. Dimensions in major depressive disorder and their relevance for treatment outcome. Journal of Affective Disorders 2014, 155:35-41.
168. Vythilingam M., Vermetten E., Anderson G.M., Luckenbaugh D., Anderson E.R., Snow J., et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biological Psychiatry 2004, 56:101-112.
169. Wagner G., Koch K., Schachtzabel C., Peikert G., Schultz C.C., Reichenbach J.R., et al. Self-referential processing influences functional activation during cognitive control: an fMRI study. Social Cognitive and Affective Neuroscience 2013, 8:828-837.
170. Wagner G., Koch K., Schachtzabel C., Sobanski T., Reichenbach J.R., Sauer H., et al. Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. Journal of Psychiatry & Neuroscience 2010, 35:247-257.
171. Walsh N.D., Williams S.C.R., Brammer M.J., Bullmore E.T., Kim J., Suckling J., et al. Alongitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biological Psychiatry 2007, 62:1236-1243.
172. Wang T., Huang X., Huang P., Li D., Lv F., Zhang Y., et al. Early-stage psychotherapy produces elevated frontal white matter integrity in adult major depressive disorder. PloS One 2013, 8:e63081.
173. Wang L., Li K., Zhang Q., Zeng Y., Dai W., Su Y., et al. Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging. Psychological Medicine 2013, 44:1417-1426.
174. Wang L., Li K., Zhang Q.E., Zeng Y.W., Jin Z., Dai W.J., et al. Interhemispheric functional connectivity and its relationships with clinical characteristics in major depressive disorder: a resting state fMRI study. PloS One 2013, 8:e60191.
175. Watson L.A., Berntsen D., Kuyken W., Watkins E.R. Involuntary and voluntary autobiographical memory specificity as a function of depression. Journal of Behavior Therapy and Experimental Psychiatry 2013, 44:7-13.
176. Zeng L.L., Shen H., Liu L., Hu D. Unsupervised classification of major depression using functional connectivity MRI. Human Brain Mapping 2013, 35:1630-1641.
177. Zhang W.N., Chang S.H., Guo L.Y., Zhang K.L., Wang J. The neural correlates of reward-related processing in major depressive disorder: a meta-analysis of functional magnetic resonance imaging studies. Journal of Affective Disorders 2013, 151:531-539.